Table 3.36: Outcomes of patients being used CRT and not being used CRT for the support of monitoring of antivenom therapy Outcomes Patient groups P Clinical + CRT (n=85) Clinical only (n=26) Median (Min-Max) Duration of antivenom therapy (hours) 10 (0, 5 - 120) 7 (1 - 23) >0, 05 Total dose of antivenom (via ls) 21 (0, 5 - 70) 38 (4 - 72) <0, 01 Decrease in the necrosis after antivenom (cm2) 0, 5 (- 0, 5 - 116) 0 (- 42 - 89) <0, 05 Hospita lization time (days) 2 (1 - 10) 3 (1 - 13) <0, 05 Note: Data are presented as n (%) Comment: - Total dose of antivenom, decrease in the necrosis and hospitalization time were lower significantly than those in groups not used CRT to guide antivenom therapy.